In today’s Pharmaceutical Executive Daily, a new study reignites debate over a potential link between Tylenol use and autism ...

Under the terms of the agreement, Pfizer is expected to pay an upfront total of $30 million in early 2026 to Novavax, while ...

TopGum Industries signed a binding letter of intent to acquire U.S.-based operations manufacturing pharmaceutical products ...

AI can accelerate drug discovery, clinical development, and patient access, but regulatory hurdles remain. Anders Romare, ...

GSK entered into a definitive agreement to acquire RAPT Therapeutics, including RAPT’s long-acting anti-immunoglobulin E (IgE ...

In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...

In today’s Pharmaceutical Executive Daily, GSK moves to strengthen its immunology pipeline with a $2 billion acquisition of ...

A new study suggests that there is no link between Tylenol and autism. More specifically, the research shows that women ...

The alternative is to purchase a fit-for-purpose solution. This approach requires in-depth investigation to ensure that the ...

Despite pledges to lower drug costs through Trump-backed pricing deals and direct-to-patient programs, pharmaceutical ...

Ahead of her presentation at JP Morgan, Pharmaceutical Technology spoke with Dr. Jennifer Levin Carter, MD, founder and CEO ...

Shanghai Henlius Biotech, Inc. announced that it entered into an exclusive global license agreement with U-mab Biopharma ...